Nutraceutical International 10-Q 30 Jan 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Dec. 31, 2013	Jan. 29, 2014
Document and Entity Information	'	'
Entity Registrant Name	'NUTRACEUTICAL INTERNATIONAL CORP	'
Entity Central Index Key	'0001050007	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--09-30	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	9,854,063
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Sep. 30, 2013
In Thousands, unless otherwise specified
Current assets	'	'
Cash	$6,107	$8,235
Accounts receivable, net	12,784	13,697
Inventories	52,496	49,329
Prepaid expenses and other current assets	2,713	2,393
Deferred income taxes	1,533	1,394
Total current assets	75,633	75,048
Property, plant and equipment, net	77,236	76,214
Goodwill	18,643	15,821
Intangible assets, net	20,829	19,080
Other non-current assets	1,289	1,313
Deferred income taxes, net	4,598	4,834
Total assets	198,228	192,310
Current liabilities	'	'
Accounts payable	14,007	14,329
Accrued expenses	7,087	7,467
Total current liabilities	21,094	21,796
Long-term debt	34,500	32,500
Other non-current liabilities	154	138
Total liabilities	55,748	54,434
Stockholders' equity	'	'
Common stock	99	98
Additional paid-in capital	15,575	15,126
Retained earnings	126,593	122,458
Accumulated other comprehensive income	213	201
Treasury stock	'	-7
Total stockholders' equity	142,480	137,876
Total liabilities and stockholders' equity	$198,228	$192,310

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME	'	'
Net sales	$51,550	$49,744
Cost of sales	25,488	25,603
Gross profit	26,062	24,141
Operating expenses	'	'
Selling, general and administrative	18,581	17,764
Amortization of intangible assets	584	572
Income from operations	6,897	5,805
Interest and other expense, net	318	311
Income before provision for income taxes	6,579	5,494
Provision for income taxes	2,444	2,000
Net income	4,135	3,494
Other comprehensive income	'	'
Foreign currency translation adjustment, net of tax	12	5
Comprehensive income	$4,147	$3,499
Net income per common share	'	'
Basic (in dollars per share)	$0.42	$0.36
Diluted (in dollars per share)	$0.42	$0.36
Weighted average common shares outstanding	'	'
Basic (in shares)	9,837,631	9,791,277
Dilutive effect of stock options (in shares)	10,028	27,150
Diluted (in shares)	9,847,659	9,818,427

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'
Net income	$4,135	$3,494
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	2,638	2,402
Amortization of deferred financing fees	46	46
Losses on disposals of property, plant and equipment	1	'
Tax benefit from stock option exercises	-51	-35
Deferred income taxes, net	97	263
Changes in assets and liabilities, net of effects of acquisitions:	'	'
Accounts receivable, net	1,254	1,080
Inventories	-2,582	827
Prepaid expenses and other current assets	-174	407
Other non-current assets	-22	-18
Accounts payable	-322	-567
Accrued expenses	460	-1,072
Other non-current liabilities	16	20
Net cash provided by operating activities	5,496	6,847
Cash flows from investing activities:	'	'
Acquisitions of businesses	-6,227	'
Purchases of property, plant and equipment	-3,077	-2,226
Net cash used in investing activities	-9,304	-2,226
Cash flows from financing activities:	'	'
Proceeds from debt	7,500	8,500
Payments on debt	-5,500	-2,500
Proceeds from issuances of common stock	152	276
Purchases of common stock for treasury	-521	-1,243
Dividends paid on common stock	'	-9,785
Tax benefit from stock option exercises	51	35
Net cash provided by (used in) financing activities	1,682	-4,717
Effect of exchange rate changes on cash	-2	20
Net decrease in cash	-2,128	-76
Cash at beginning of period	8,235	4,824
Cash at end of period	$6,107	$4,748

BASIS_OF_PRESENTATION

BASIS OF PRESENTATION	3 Months Ended
	Dec. 31, 2013
BASIS OF PRESENTATION	'
BASIS OF PRESENTATION	'
	1. BASIS OF PRESENTATION
	Nutraceutical International Corporation and its subsidiaries (the "Company") is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. The Company's core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company believes that the consolidation and integration of these acquired businesses provide ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.
	The Company manufactures and sells nutritional supplements and other natural products under numerous brands including Solaray®, KAL®, Nature's Life®, LifeTime®, Natural Balance®, bioAllers®, Herbs for Kids®, NaturalCare®, Health from the Sun®, Life-flo®, Organix South®, Pioneer® and Monarch Nutraceuticals™.
	The Company owns neighborhood natural food markets, which operate under the trade names The Real Food Company™, Thom's Natural Foods™ and Cornucopia Community Market™. The Company also owns health food stores, which operate under various trade names including Fresh Vitamins™, Granola's™, Nature's Discount® and Warehouse Vitamins™.
	In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all necessary adjustments, consisting of normal recurring adjustments, to state fairly the consolidated financial position of the Company as of December 31, 2013, the results of its operations and cash flows for the three months ended December 31, 2013 and 2012, in conformity with accounting principles generally accepted in the United States of America for interim financial information applied on a consistent basis. Results for the three months ended December 31, 2013 are not necessarily indicative of the results to be expected for the full fiscal year.
	Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been omitted. Accordingly, these financial statements should be read in conjunction with the Company's Form 10-K for the fiscal year ended September 30, 2013, which was filed with the Securities and Exchange Commission on November 26, 2013.
	Use of Estimates
	The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America required management to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Significant estimates included values and lives assigned to acquired intangible assets, reserves for customer returns and allowances, uncollectible accounts receivable, valuation adjustments for slow moving, obsolete and/or damaged inventory and valuation and recoverability of long-lived assets. Actual results may differ from these estimates.
	New Accounting Standards
	The Company reviews new accounting standards as they are issued. Although some of these accounting standards may be applicable to the Company, the Company has not identified any new standards that the Company believes merit further discussion, and the Company expects that none would have a significant impact on the Company's consolidated financial statements.

ACCOUNTS_RECEIVABLE

ACCOUNTS RECEIVABLE	3 Months Ended
	Dec. 31, 2013
ACCOUNTS RECEIVABLE	'
ACCOUNTS RECEIVABLE	'
	2. ACCOUNTS RECEIVABLE
	Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:
		December 31,			September 30,
		2013			2013
	Accounts receivable	$	14,355		$	15,349
	Less allowances		(1,571	)		(1,652	)
		$	12,784		$	13,697

INVENTORIES

INVENTORIES	3 Months Ended
	Dec. 31, 2013
INVENTORIES	'
INVENTORIES	'
	3. INVENTORIES
	Inventories were comprised of the following:
		December 31,		September 30,
		2013		2013
	Raw materials	$	20,752	$	18,221
	Work-in-process		5,908		6,048
	Finished goods		25,836		25,060
		$	52,496	$	49,329

ACQUISITIONS

ACQUISITIONS	3 Months Ended
	Dec. 31, 2013
ACQUISITIONS	'
ACQUISITIONS	'
	4. ACQUISITIONS
	During the three months ended December 31, 2013, the Company made three acquisitions of businesses. On October 16, 2013, the Company acquired certain operating assets of TCCD International, Inc. On November 25, 2013, the Company acquired certain operating assets of Green Luxury Brands, Inc. On December 19, 2013, the Company acquired certain operating assets of Twinlab Corporation. The aggregate purchase price of these acquisitions was $6,227 in cash. During the three months ended December 31, 2012, the Company made no acquisitions of businesses.
	The Condensed Consolidated Statements of Operations and Comprehensive Income and the Condensed Consolidated Statements of Cash Flows presented herein include the activities of these acquired businesses from their respective dates of acquisition. The expected long-term sales and expense synergies of acquired businesses generally are not realized immediately following acquisition as certain transition and integration matters must be completed.
	These acquisitions are in keeping with the Company's business strategy of consolidating the fragmented industry in which it competes and were accounted for using the acquisition method of accounting. Accordingly, the aggregate purchase price was assigned to the assets acquired based on their fair values at their respective dates of acquisition. The excess of aggregate purchase price over the fair values of the assets acquired was classified as goodwill. The goodwill relates to expected synergies from these acquisitions. The following reflects the preliminary allocation of the aggregate purchase price for these acquisitions to the aggregate assets acquired:
		Fiscal 2014
		Acquisitions
	Aggregate assets acquired:
	Current assets	$	1,072
	Goodwill		2,822
	Intangible assets		2,333
		$	6,227
	The acquired intangible assets totaling $2,333 related to trademarks, tradenames and customer relationships, which are being amortized over periods of two to twelve years for financial statement purposes, are expected to be deductible for tax purposes over fifteen years. Goodwill of $2,822, which is not subject to amortization for financial statement purposes, is expected to be deductible for tax purposes over fifteen years.

GOODWILL_AND_INTANGIBLE_ASSETS

GOODWILL AND INTANGIBLE ASSETS	3 Months Ended
	Dec. 31, 2013
GOODWILL AND INTANGIBLE ASSETS	'
GOODWILL AND INTANGIBLE ASSETS	'
	5. GOODWILL AND INTANGIBLE ASSETS
	The change in the carrying amount of goodwill from September 30, 2013 to December 31, 2013 was as follows:
		Goodwill
	Balance as of September 30, 2013
	Goodwill	$	56,215
	Accumulated impairment losses		(40,394	)
			15,821
	Goodwill attributable to fiscal 2014 acquisitions		2,822
	Balance as of December 31, 2013
	Goodwill		59,037
	Accumulated impairment losses		(40,394	)
		$	18,643
	The carrying amounts of intangible assets at December 31, 2013 and September 30, 2013 were as follows:
		December 31, 2013								September 30, 2013
																	Weighted-
																	Average
																	Amortization
		Gross			Accumulated			Net		Gross		Accumulated			Net		Period (Years)
		Carrying			Amortization(1)			Carrying		Carrying		Amortization(1)			Carrying
		Amount(1)						Amount		Amount(1)					Amount
	Intangible assets subject to amortization:
	Trademarks/tradenames/patents	$	4,284		$	(1,148	)	$	3,136	$	3,819	$	(1,053	)	$	2,766		13
	Customer relationships/distribution rights/non-compete agreements		13,306			(5,639	)		7,667		11,141		(5,150	)		5,991		6
	Developed software and technology		772			(772	)		—		772		(772	)		—		5
			18,362			(7,559	)		10,803		15,732		(6,975	)		8,757
	Intangible assets not subject to amortization:
	Trademarks/tradenames/licenses		10,026			—			10,026		10,323		—			10,323
		$	28,388		$	(7,559	)	$	20,829	$	26,055	$	(6,975	)	$	19,080
	-1
	Amounts include the impact of foreign currency translation adjustments.
	Estimated future amortization expense related to the December 31, 2013 net carrying amount of $10,803 for intangible assets subject to amortization is as follows:
	Year Ending September 30,	Estimated
		Amortization
		Expense
	2014(1)	$	1,843
	2015		2,293
	2016		1,654
	2017		1,296
	2018		1,105
	Thereafter		2,612
		$	10,803
	-1
	Estimated amortization expense for the year ending September 30, 2014 includes only amortization to be recorded after December 31, 2013.
	The ongoing uncertainty in general and economic conditions may continue to impact retail and consumer demand, as well as the market price of the Company's common stock, and could negatively impact the Company's future operating performance, cash flow and/or stock price and could result in goodwill and/or intangible asset impairment charges being recorded in future periods. Also, the Company periodically reviews its brands to achieve marketing, sales and operational synergies. These reviews could result in brands being consolidated or discontinued and could result in additional intangible asset impairment charges being recorded in future periods. Additional goodwill and/or intangible asset impairment charges could materially impact the Company's consolidated financial statements. The valuation of goodwill and intangible assets is subject to a high degree of judgment, uncertainty and complexity.

DEBT

DEBT	3 Months Ended
	Dec. 31, 2013
DEBT	'
DEBT	'
	6. DEBT
	Debt was comprised of the following:
		December 31,		September 30,
		2013		2013
	Long-term debt—revolving credit facility	$	34,500	$	32,500
	The Company's debt is stated at book value which approximated its fair value at December 31, 2013 and September 30, 2013. Estimated fair values for debt have been determined based on borrowing rates currently available to the Company for bank loans with similar terms and maturities and are classified as Level 2 (significant observable inputs other than quoted prices) in the FASB's fair value hierarchy.
	On December 17, 2010, the Company amended and restated its revolving credit facility (the "Restated Credit Agreement"). The Restated Credit Agreement extends the term of the credit facility to December 2015, resets the available credit borrowings to $90,000 with no automatic reductions and provides an accordion feature that can increase the available credit borrowings to $120,000 subject to approval by the lenders and compliance with certain covenants and conditions. The lenders under the Restated Credit Agreement are Rabobank International and Wells Fargo. To date, the Company has not experienced any difficulties in accessing the available funds under the Restated Credit Agreement. Deferred financing fees of $878 related to the Restated Credit Agreement are being amortized over the term of the Restated Credit Agreement.
	At December 31, 2013, the Company had outstanding revolving credit borrowings of $34,500 under the Restated Credit Agreement. Borrowings under the Restated Credit Agreement are collateralized by substantially all assets of the Company. At the Company's election, borrowings bear interest at the applicable Eurodollar Rate plus a variable margin or at a base rate, which is the higher of the Federal Funds Rate plus 0.5% or the Prime Lending Rate, plus a variable margin. At December 31, 2013, the applicable weighted-average interest rate for outstanding borrowings was 2.25%. The Company is also required to pay a quarterly fee of 0.50% on the unused balance under the Restated Credit Agreement. Accrued interest on Eurodollar Rate borrowings is payable based on elected intervals of one, two or three months. Accrued interest on base rate borrowings is payable quarterly. The Restated Credit Agreement matures on December 15, 2015, and the Company is required to repay all principal and interest outstanding under the Restated Credit Agreement on such date.
	The Restated Credit Agreement contains restrictive covenants, including limitations on incurring other indebtedness and requirements that the Company maintain certain financial ratios. As of December 31, 2013, the Company was in compliance with the restrictive covenants. Upon the occurrence of a default, the lender has various remedies or rights, which may include proceeding against the collateral or requiring the Company to repay all amounts outstanding under the Restated Credit Agreement.

SHARE_PURCHASES

SHARE PURCHASES	3 Months Ended
	Dec. 31, 2013
SHARE PURCHASES	'
SHARE PURCHASES	'
	7. SHARE PURCHASES
	During the three months ended December 31, 2013 and 2012, the Company purchased 21,705 and 78,403 shares of common stock for an aggregate price of $521 and $1,243, respectively. All shares of common stock held in treasury were retired prior to December 31 in the respective quarter of purchase except at December 31, 2012 the Company held 2,000 shares of common stock in treasury. As of December 31, 2013, the Company was permitted to purchase up to 921,160 additional shares under its approved purchase plan. The Company accounts for treasury shares using the cost method.

STOCK_OPTIONS_AND_OTHER_EQUITY

STOCK OPTIONS AND OTHER EQUITY AWARDS	3 Months Ended
	Dec. 31, 2013
STOCK OPTIONS AND OTHER EQUITY AWARDS	'
STOCK OPTIONS	'
	8. STOCK OPTIONS AND OTHER EQUITY AWARDS
	The following table summarizes stock option activity during the three months ended December 31, 2013:
		Number of			Weighted-Average
		Options			Exercise
					Price
	Options outstanding and exercisable at September 30, 2013		42,500		$	13.59
	Exercised		(10,000	)		11.53
	Options outstanding and exercisable at December 31, 2013		32,500			14.22
	No options to purchase shares of common stock for the three months ended December 31, 2013 and 2012 were excluded from the computation of diluted earnings per share because the exercise prices of all stock options were less than the average share price of the Company's common stock.
	During the three months ended December 31, 2013, the Company received proceeds of $115 related to the exercise of stock options. During this same period, the Company recorded a tax benefit of $51 and optionees realized an aggregate pre-tax gain of $133 from these stock option exercises. During the three months ended December 31, 2012, the Company received proceeds of $263 related to the exercise of stock options. During this same period, the Company recorded a tax benefit of $35 and optionees realized an aggregate pre-tax gain of $91 from these stock option exercises.
	On January 28, 2013, stockholders approved the Nutraceutical International Corporation 2013 Long-Term Equity Incentive Plan (the "2013 Plan") and the reservation of 800,000 shares of the Company's common stock for issuance under the 2013 Plan. Equity awards available under the 2013 Plan include stock options, stock appreciation rights and stock awards. In conjunction with the Company's fiscal 2013 incentive compensation (bonus) payments, 31,788 shares of the Company's common stock were issued. These non-cash stock awards were granted on December 11, 2013 at a fair value of $775, with fair value being determined by the closing price of the company's common stock on the grant date. These stock awards were registered, unrestricted and fully vested on the grant date. As of December 31, 2013, 768,212 shares of the Company's common stock are available for issuance under the 2013 Plan.

DIVIDENDS

DIVIDENDS	3 Months Ended
	Dec. 31, 2013
DIVIDENDS	'
DIVIDENDS	'
	9. DIVIDENDS
	In December 2012, the Company's board of directors declared a special cash dividend of $1.00 per share for all shares of common stock. This special cash dividend totaled $9,785 and was paid on December 28, 2012 to stockholders of record on December 21, 2012.

SEGMENTS

SEGMENTS	3 Months Ended
	Dec. 31, 2013
SEGMENTS	'
SEGMENTS	'
	10. SEGMENTS
	Segment identification and selection is consistent with the management structure used by the Company to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company's management structure and method of internal reporting, the Company has one operating segment. The Company does not review operating results on a disaggregated basis; rather, management reviews operating results on an aggregate basis.
	Net sales attributed to customers in the United States and foreign countries for the three months ended December 31, 2013 and 2012 were as follows:
		Three months ended
		December 31,
		2013		2012
	United States	$	45,323	$	43,381
	Foreign countries		6,227		6,363
		$	51,550	$	49,744
	Certain net sales attributed to customers in the United States are sold to customers who in turn may sell such products to customers in foreign countries while certain net sales attributed to customers in foreign countries are sold to customers who in turn may sell such products to customers in the United States.
	The Company's net sales by product group for the three months ended December 31, 2013 and 2012 were as follows:
		Three months ended
		December 31,
		2013		2012
	Branded nutritional supplements and other natural products	$	46,972	$	45,004
	Other(1)		4,578		4,740
		$	51,550	$	49,744
	-1
	Net sales for any other product or group of similar products are less than 10% of consolidated net sales.

SUBSEQUENT_EVENT

SUBSEQUENT EVENT	3 Months Ended
	Dec. 31, 2013
SUBSEQUENT EVENT	'
SUBSEQUENT EVENT	'
	11. SUBSEQUENT EVENT
	On January 15, 2014, the Company acquired certain operating assets of Peachtree Natural Foods, Inc. for approximately $2,900 in cash. The primary assets acquired in this acquisition included accounts receivable, inventory, prepaid expenses, trademarks/tradenames, customer relationships and goodwill. As of the date of these financial statements, the Company is determining the fair value of the acquired assets and the related allocation of the purchase price.

ACCOUNTS_RECEIVABLE_Tables

ACCOUNTS RECEIVABLE (Tables)	3 Months Ended
	Dec. 31, 2013
ACCOUNTS RECEIVABLE	'
Schedule of accounts receivable, net of allowances for sales returns and doubtful accounts	'
		December 31,			September 30,
		2013			2013
	Accounts receivable	$	14,355		$	15,349
	Less allowances		(1,571	)		(1,652	)
		$	12,784		$	13,697

INVENTORIES_Tables

INVENTORIES (Tables)	3 Months Ended
	Dec. 31, 2013
INVENTORIES	'
Schedule of inventories	'
		December 31,		September 30,
		2013		2013
	Raw materials	$	20,752	$	18,221
	Work-in-process		5,908		6,048
	Finished goods		25,836		25,060
		$	52,496	$	49,329

ACQUISITIONS_Tables

ACQUISITIONS (Tables)	3 Months Ended
	Dec. 31, 2013
ACQUISITIONS	'
Schedule of preliminary allocation of the aggregate purchase price for the acquisitions to the aggregate assets acquired	'
		Fiscal 2014
		Acquisitions
	Aggregate assets acquired:
	Current assets	$	1,072
	Goodwill		2,822
	Intangible assets		2,333
		$	6,227

GOODWILL_AND_INTANGIBLE_ASSETS1

GOODWILL AND INTANGIBLE ASSETS (Tables)	3 Months Ended
	Dec. 31, 2013
GOODWILL AND INTANGIBLE ASSETS	'
Schedule of changes in the carrying amount of goodwill	'
		Goodwill
	Balance as of September 30, 2013
	Goodwill	$	56,215
	Accumulated impairment losses		(40,394	)
			15,821
	Goodwill attributable to fiscal 2014 acquisitions		2,822
	Balance as of December 31, 2013
	Goodwill		59,037
	Accumulated impairment losses		(40,394	)
		$	18,643
Schedule of carrying amounts of intangible assets	'
		December 31, 2013								September 30, 2013
																	Weighted-
																	Average
																	Amortization
		Gross			Accumulated			Net		Gross		Accumulated			Net		Period (Years)
		Carrying			Amortization(1)			Carrying		Carrying		Amortization(1)			Carrying
		Amount(1)						Amount		Amount(1)					Amount
	Intangible assets subject to amortization:
	Trademarks/tradenames/patents	$	4,284		$	(1,148	)	$	3,136	$	3,819	$	(1,053	)	$	2,766		13
	Customer relationships/distribution rights/non-compete agreements		13,306			(5,639	)		7,667		11,141		(5,150	)		5,991		6
	Developed software and technology		772			(772	)		—		772		(772	)		—		5
			18,362			(7,559	)		10,803		15,732		(6,975	)		8,757
	Intangible assets not subject to amortization:
	Trademarks/tradenames/licenses		10,026			—			10,026		10,323		—			10,323
		$	28,388		$	(7,559	)	$	20,829	$	26,055	$	(6,975	)	$	19,080
	-1
	Amounts include the impact of foreign currency translation adjustments.
Schedule of estimated amortization expense related to intangible assets subject to amortization	'
	Year Ending September 30,	Estimated
		Amortization
		Expense
	2014(1)	$	1,843
	2015		2,293
	2016		1,654
	2017		1,296
	2018		1,105
	Thereafter		2,612
		$	10,803
	-1
	Estimated amortization expense for the year ending September 30, 2014 includes only amortization to be recorded after December 31, 2013.

DEBT_Tables

DEBT (Tables)	3 Months Ended
	Dec. 31, 2013
DEBT	'
Schedule of debt	'
		December 31,		September 30,
		2013		2013
	Long-term debt—revolving credit facility	$	34,500	$	32,500

STOCK_OPTIONS_AND_OTHER_EQUITY1

STOCK OPTIONS AND OTHER EQUITY AWARDS (Tables)	3 Months Ended
	Dec. 31, 2013
STOCK OPTIONS AND OTHER EQUITY AWARDS	'
Schedule of stock option activity	'
		Number of			Weighted-Average
		Options			Exercise
					Price
	Options outstanding and exercisable at September 30, 2013		42,500		$	13.59
	Exercised		(10,000	)		11.53
	Options outstanding and exercisable at December 31, 2013		32,500			14.22

SEGMENTS_Tables

SEGMENTS (Tables)	3 Months Ended
	Dec. 31, 2013
SEGMENTS	'
Schedule of net sales attributed to customers in the United States and foreign countries	'
		Three months ended
		December 31,
		2013		2012
	United States	$	45,323	$	43,381
	Foreign countries		6,227		6,363
		$	51,550	$	49,744
Schedule of net sales by product group	'
		Three months ended
		December 31,
		2013		2012
	Branded nutritional supplements and other natural products	$	46,972	$	45,004
	Other(1)		4,578		4,740
		$	51,550	$	49,744
	-1
	Net sales for any other product or group of similar products are less than 10% of consolidated net sales.

ACCOUNTS_RECEIVABLE_Details

ACCOUNTS RECEIVABLE (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013
In Thousands, unless otherwise specified
ACCOUNTS RECEIVABLE	'	'
Accounts receivable	$14,355	$15,349
Less allowances	-1,571	-1,652
Accounts receivable, net	$12,784	$13,697

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013
In Thousands, unless otherwise specified
INVENTORIES	'	'
Raw materials	$20,752	$18,221
Work-in-process	5,908	6,048
Finished goods	25,836	25,060
Inventories	$52,496	$49,329

ACQUISITIONS_Details

ACQUISITIONS (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2013
	item	item
ACQUISITIONS	'	'	'
Number of business acquisitions	3	0	'
Aggregate assets acquired:	'	'	'
Goodwill	$18,643	'	$15,821
Trademarks, tradenames and customer relationships | Minimum	'	'	'
Aggregate assets acquired:	'	'	'
Amortization period	'2 years	'	'
Trademarks, tradenames and customer relationships | Maximum	'	'	'
Aggregate assets acquired:	'	'	'
Amortization period	'12 years	'	'
Acquisitions	'	'	'
ACQUISITIONS	'	'	'
Aggregate purchase price in cash	6,227	'	'
Aggregate assets acquired:	'	'	'
Current assets	1,072	'	'
Goodwill	2,822	'	'
Intangible assets	2,333	'	'
Aggregate purchase price	6,227	'	'
Acquired intangible assets expected to be deductible for tax purposes	2,333	'	'
Goodwill expected to be deductible for tax purposes	$2,822	'	'
Expected period for deduction of acquired intangible assets for tax purposes	'15 years	'	'
Expected period for deduction of acquired goodwill for tax purposes	'15 years	'	'

GOODWILL_AND_INTANGIBLE_ASSETS2

GOODWILL AND INTANGIBLE ASSETS (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013
GOODWILL	'	'
Goodwill	$59,037	$56,215
Accumulated impairment losses	-40,394	-40,394
Carrying amount of goodwill	18,643	15,821
Goodwill attributable to fiscal 2014 acquisitions	2,822	'
Intangible assets subject to amortization:	'	'
Gross Carrying Amount	18,362	15,732
Accumulated Amortization	-7,559	-6,975
Net Carrying Amount	10,803	8,757
Total intangible assets	'	'
Gross Carrying Amount	28,388	26,055
Net Carrying Amount	20,829	19,080
Estimated future amortization expense related to intangible assets	'	'
2014	1,843	'
2015	2,293	'
2016	1,654	'
2017	1,296	'
2018	1,105	'
Thereafter	2,612	'
Net Carrying Amount	10,803	8,757
Trademarks/tradenames/licenses	'	'
Intangible assets not subject to amortization:	'	'
Carrying Amount	10,026	10,323
Trademarks/tradenames/patents	'	'
Intangible assets subject to amortization:	'	'
Gross Carrying Amount	4,284	3,819
Accumulated Amortization	-1,148	-1,053
Net Carrying Amount	3,136	2,766
Estimated future amortization expense related to intangible assets	'	'
Net Carrying Amount	3,136	2,766
Trademarks/tradenames/patents | Weighted average	'	'
Intangible assets subject to amortization:	'	'
Weighted-Average Amortization Period	'13 years	'
Customer relationships/distribution rights/ non-compete agreements	'	'
Intangible assets subject to amortization:	'	'
Gross Carrying Amount	13,306	11,141
Accumulated Amortization	-5,639	-5,150
Net Carrying Amount	7,667	5,991
Estimated future amortization expense related to intangible assets	'	'
Net Carrying Amount	7,667	5,991
Customer relationships/distribution rights/ non-compete agreements | Weighted average	'	'
Intangible assets subject to amortization:	'	'
Weighted-Average Amortization Period	'6 years	'
Developed software and technology	'	'
Intangible assets subject to amortization:	'	'
Gross Carrying Amount	772	772
Accumulated Amortization	($772)	($772)
Developed software and technology | Weighted average	'	'
Intangible assets subject to amortization:	'	'
Weighted-Average Amortization Period	'5 years	'

DEBT_Details

DEBT (Details) (USD $)	Dec. 31, 2013	Sep. 30, 2013	Dec. 17, 2010	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
In Thousands, unless otherwise specified			Restated Credit Agreement	Restated Credit Agreement	Restated Credit Agreement	Restated Credit Agreement	Restated Credit Agreement	Restated Credit Agreement, accordion feature
					Federal Funds Rate	Eurodollar Rate	Prime Lending Rate
DEBT	'	'	'	'	'	'	'	'
Long-term debt-revolving credit facility	$34,500	$32,500	'	'	'	'	'	'
Available credit borrowings	'	'	90,000	'	'	'	'	120,000
Amount of automatic reduction	'	'	0	'	'	'	'	'
Deferred financing cost	'	'	878	'	'	'	'	'
Outstanding revolving credit borrowings	'	'	'	$34,500	'	'	'	'
Reference rate	'	'	'	'	'Federal Funds Rate	'Eurodollar Rate	'Prime Lending Rate	'
Margin over reference rate (as a percent)	'	'	'	'	0.50%	'	'	'
Weighted-average interest rate (as a percent)	'	'	'	2.25%	'	'	'	'
Quarterly fee on the unused balance (as a percent)	'	'	'	0.50%	'	'	'	'
Interval for payment of accrued interest under option one	'	'	'	'	'	'1 month	'	'
Interval for payment of accrued interest under option two	'	'	'	'	'	'2 months	'	'
Interval for payment of accrued interest under option three	'	'	'	'	'	'3 months	'	'

SHARE_PURCHASES_Details

SHARE PURCHASES (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
SHARE PURCHASES	'	'
Additional number of shares authorized to be repurchased	921,160	'
Common Stock	'	'
SHARE PURCHASES	'	'
Shares of common stock purchased	21,705	78,403
Aggregate price at which shares of common stock are purchased (in dollars)	$521	$1,243
Number of shares of common stock held in treasury	'	2,000

STOCK_OPTIONS_AND_OTHER_EQUITY2

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details) (USD $)	3 Months Ended
	Dec. 31, 2013
Number of Options	'
Options outstanding and exercisable at the beginning of the period (in shares)	42,500
Exercised (in shares)	-10,000
Options outstanding and exercisable at the end of the period (in shares)	32,500
Weighted-Average Exercise Price	'
Options outstanding and exercisable at the beginning of the period (in dollars per share)	$13.59
Exercised (in dollars per share)	$11.53
Options outstanding and exercisable at the ending of the period (in dollars per share)	$14.22

STOCK_OPTIONS_AND_OTHER_EQUITY3

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 2) (Stock options)	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stock options	'	'
Antidilutive securities	'	'
Options to purchase shares of common stock excluded from the computation of diluted earnings per share (in shares)	0	0

STOCK_OPTIONS_AND_OTHER_EQUITY4

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 3) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
STOCK OPTIONS AND OTHER EQUITY AWARDS	'	'
Proceeds from exercise of stock options	$115	$263
Tax benefit from stock option exercises	51	35
Pre-tax gain from exercise of stock options	$133	$91

STOCK_OPTIONS_AND_OTHER_EQUITY5

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 4) (2013 Plan, USD $)	0 Months Ended	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 11, 2013	Dec. 31, 2013	Jan. 28, 2013
2013 Plan	'	'	'
STOCK OPTIONS AND OTHER EQUITY AWARDS	'	'	'
Shares of common stock reserved for issuance	'	'	800,000
Shares of common stock issued	'	31,788	'
Fair value of non-cash stock awards granted and vested	$775	'	'
Shares of common stock available for issuance	'	768,212	'

DIVIDENDS_Details

DIVIDENDS (Details) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 28, 2012	Dec. 31, 2012	Dec. 31, 2012
DIVIDENDS	'	'	'
Special cash dividend (in dollars per share)	'	$1	'
Special cash dividend paid (in dollars)	$9,785	'	$9,785

SEGMENTS_Details

SEGMENTS (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
	segment
SEGMENTS	'	'
Number of operating segments	1	'
SEGMENTS	'	'
Net sales	$51,550	$49,744
Branded nutritional supplements and other natural products	'	'
SEGMENTS	'	'
Net sales	46,972	45,004
Other	'	'
SEGMENTS	'	'
Net sales	4,578	4,740
United States	'	'
SEGMENTS	'	'
Net sales	45,323	43,381
Foreign countries	'	'
SEGMENTS	'	'
Net sales	$6,227	$6,363

SUBSEQUENT_EVENT_Details

SUBSEQUENT EVENT (Details) (Subsequent event, Peachtree Natural Foods, Inc., USD $)	0 Months Ended
In Thousands, unless otherwise specified	Jan. 15, 2014
Subsequent event | Peachtree Natural Foods, Inc.	'
SUBSEQUENT EVENT	'
Aggregate purchase price in cash	$2,900